key: cord-0975578-24v74ner authors: Kuijlaars, Isolde A. R.; Teela, Lorynn; van Vulpen, Lize F. D.; Timmer, Merel A.; Coppens, Michiel; Gouw, Samantha C.; Peters, Marjolein; Kruip, Marieke J. H. A.; Cnossen, Marjon H.; Muis, Jelmer J.; van Hoorn, Evelien S.; Haverman, Lotte; Fischer, Kathelijn title: Generic PROMIS item banks in adults with hemophilia for patient‐reported outcome assessment: Feasibility, measurement properties, and relevance date: 2021-11-21 journal: Res Pract Thromb Haemost DOI: 10.1002/rth2.12621 sha: f594110b80ac6c0d9a0b5a02b33bb457655f8adc doc_id: 975578 cord_uid: 24v74ner BACKGROUND: Legacy hemophilia‐specific questionnaires are considered too long, show floor‐/ceiling effects, and/or include irrelevant questions. Patient Reported Outcomes Measurement Information System (PROMIS) item banks, including Computer Adaptive Tests (CATs) and short forms, were designed for more efficient outcome assessment. OBJECTIVES: Evaluate the feasibility, measurement properties, and relevance of seven PROMIS CATs and two short forms in patients with hemophilia. PATIENTS/METHODS: In this cross‐sectional study, Dutch adults with hemophilia completed nine PROMIS item banks electronically. Feasibility was assessed by number of items and floor/ceiling effects. Reliability was determined as the proportion of reliable scores (standard error ≤3.2). Construct validity was assessed by comparison with legacy instruments and expected differences between subgroups. Relevance of item banks was determined by proportions of limited scores. RESULTS: Overall, 142 of 373 invited patients (mean age, 47 [range, 18‐79], 49% severe hemophilia, 46% receiving prophylaxis) responded. Per CAT item bank, mean number of items answered varied from 5 (range, 3‐12) to 9 (range, 5‐12), with floor effects in pain interference (26% lowest scores) and depression (18% lowest scores). Construct validity and reliability were good for physical function, pain interference, satisfaction with social roles and activities, and fatigue. The CAT physical function showed the most limited scores (38%). The self‐efficacy short forms showed ceiling effects (22%‐28%) and no relation with the legacy instruments. CONCLUSIONS: The PROMIS CATs physical function, pain interference, satisfaction with social roles and activities, and fatigue are feasible, reliable, and valid alternatives to legacy instruments for patients with hemophilia, with few items and low floor‐/ceiling effects. Clinical management and therapeutic options for hemophilia have greatly improved in the past decades in resource-rich countries, from prophylactic clotting factor replacement therapy to prevent bleeding, 1 introduced in the Netherlands in 1968, to current ongoing hemophilia gene therapy trials 2 and upcoming nonreplacement therapy development and implementation since 2017. 3 Logically, outcome has also improved, from reduced life expectancy and development of painful crippling arthropathy at an early age to a near-normal life expectancy and participation in contact sports. 4, 5 Currently, comprehensive care with a focus on physical and psychosocial health is Tests (CATs), where the next item presented to the patient depends on the response to earlier items. As a consequence, it is not necessary to answer all items of the patient-reported outcome measure. This system lowers the burden of outcome assessment by administering a limited number of more relevant questions with a higher reliability. 8 For example, the HAL contains 42 items versus a mean of 4 to 6 PROMIS physical functioning CAT items. 9 When CATs are not available or information technology (IT) facilities and budget are limited, static PROMIS short forms with a selection of items are a reliable alternative. 10 An additional advantage is that PROMIS item banks are generic and patients do not need to complete different questionnaires for every comorbidity, resulting in a lower burden for the patient. This aspect is increasingly relevant to patients with hemophilia who experience an increasing life expectancy and as a result acquire more comorbidities associated with aging. 5 Furthermore, the occurrence of floor and ceiling effects, a frequent limitation of the HAL and Short Form-36 (SF- 36) , are minimalized in PROMIS item banks based on item selection over the whole score range. 9,11-14 A large set of PROMIS item banks has been translated and validated in the Dutch general population and several patient populations. [15] [16] [17] [18] However, PROMIS item banks have not yet been validated in adults with hemophilia and were to date seldom applied in hemophilia research projects. [19] [20] [21] Therefore, this study aimed to evaluate (i) feasibility, (ii) measurement properties, and (iii) relevance of nine PROMIS CATs and short forms for Dutch adult patients with hemophilia. We hypothesized that PROMIS CATs and short forms Results: Overall, 142 of 373 invited patients (mean age, 47 [range, , 49% severe hemophilia, 46% receiving prophylaxis) responded. Per CAT item bank, mean number of items answered varied from 5 (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] to 9 (range, [5] [6] [7] [8] [9] [10] [11] [12] , with floor effects in pain interference (26% lowest scores) and depression (18% lowest scores). Construct validity and reliability were good for physical function, pain interference, satisfaction with social roles and activities, and fatigue. The CAT physical function showed the most limited scores (38%). The self-efficacy short forms showed ceiling effects (22%-28%) and no relation with the legacy instruments. The PROMIS CATs physical function, pain interference, satisfaction with social roles and activities, and fatigue are feasible, reliable, and valid alternatives to legacy instruments for patients with hemophilia, with few items and low floor-/ceiling effects. hemophilia, patient-reported outcome, questionnaire, reliability, validity are feasible alternatives to legacy instruments for patients with hemophilia. V2.0, ability to participate in social roles and activities (participation); V2.0, satisfaction with social roles and activities (satisfaction with participation); and V1.0, fatigue. 15 For two items banks no CAT was available; these were assessed as short form with 8 questions: V1.0, self-efficacy for managing medications and treatment (self-efficacy medications); and V1.0, self-efficacy for managing symptoms (selfefficacy symptoms). All item banks use a 5-point Likert scale. The CATs automatically stopped when the standard error (SE) was ≤2.2 (95% reliability) and/or a maximum of 12 items was administered. PROMIS total scores are calculated by transforming the item scores into T scores, based on US population data, with a mean of 50 and a standard deviation (SD) of 10. For all item banks, higher scores represent more presence of the construct (eg, more pain interference or better physical function). The scores of the short forms were calculated in the PROMIS Assessment Center Scoring Service. All item banks cover a 7-day recall period, except from the physical function and participation, which do not use a recall period, and the selfefficacy item banks, which ask the current level of confidence. The HAL is a validated instrument for assessment of self-reported limitations in activities and participation in patients with hemophilia. 24, 25 The internal consistency of the HAL was high (Cronbach's α, 0.97-0.98). 24, 26 The RAND-36 measures health-related quality of life across 8 domains ('physical functioning, role limitations due to physical health problems, bodily pain, general health, energy/fatigue, social functioning, role limitations due to emotional health problems, and emotional well-being), and construct validity has been studied in patients with hemophilia. 27 In six of eight domains, patients score the items on a 3-to 6-point Likert scale, and in two of eight domains, patients score yes or no. Scores range from 0 to 100, with higher scores indicating better health status. The recall period varies from at this moment to the last four weeks. 28, 29 The internal consistency of the RAND-36 was high (Cronbach's α, 0.78-0.95). 30 The HEP-test-Q is a validated questionnaire for the assessment of subjective physical performance in patients with hemophilia. The HEP-test-Q consists of 25 items pertaining to four domains (mobility, strength & coordination, endurance, and body perception). The response options are a 5-point Likert scale (never to always). Subscales and the total score were transformed to a scale ranging from 0 to 100, with high scores indicating better physical performance. The HEP-test-Q used a recall period of 4 weeks, except for two items assessing physical activity: at this moment and compared to the last year. 31 The internal consistency of the HEP-test-Q was high (Cronbach's α, 0.96). 31 The VERITAS-Pro is a validated questionnaire for the assessment of prophylactic treatment adherence in patients with hemophilia. The 24-item questionnaire consists of six subscales (time, dose, plan, remember, skip, communicate). The response options were a 5-point Likert scale (always to never). The score ranges from 100 to 0, with an optimum score of 0. The VERITAS-Pro has a recall period of 3 months. 32 The VERITAS-Pro was available only for patients on prophylactic treatment. The internal consistency of the VERITAS-Pro was high (Cronbach's α, 0.92). 32 The PAM-13 measures patient knowledge, skills, and confidence for self-management. All 13 items have five possible responses, with scores ranging from 1 (disagree strongly) to 4 (agree strongly) or 0 (not applicable). The PAM-13 has a calibrated scale range from 38.6 to 53.0 (on a theoretical 0-100 point scale, with 100 as the optimum score). The PAM-13 does not specify a recall period. 33, 34 In the general population, internal consistency of the PAM-13 was high (Cronbach's α, 0.88). 34 SPSS, version 25 (IBM, Armonk, NY, USA) was used for data analyses. Complete case analyses were performed in the case of missing data. Patient characteristics were presented as proportions or means (SD). To determine the feasibility of PROMIS CATs and short forms, floor and ceiling effects were evaluated. Floor effects were defined as >15% of the patients reported the lowest possible score, and ceiling effects were defined as >15% reported the highest possible score. 35 In addition, for the CATs the number of items (mean [SD], range) completed by patients with hemophilia were evaluated. For the legacy instruments, floor and ceiling effects were evaluated and number of items described. Both the floor and ceiling effects and number of items were compared between the PROMIS item banks and the legacy instruments. Data on time to administer the legacy instruments and PROMIS CATs and short forms were not available. To determine which item banks were relevant to adults with hemophilia, descriptive analyses (mean T scores and SD, range) were performed for the PROMIS item banks. For the PROMIS CATs pain interference, physical function, depression, anxiety, participation, and fatigue T scores were categorized in the following categories: within normal limits, mildly-(0.5 SD), moderately (1 SD), or severely (2 SD) deviant. For the PROMIS CAT satisfaction with participation T scores were categorized as very high (+2 SD), high (+1 SD), average, low (−1 SD), and very low (−2 SD) for the construct being measured. Reference data from the general Dutch male population were used to determine the score cutoff points for these seven PROMIS item banks, according to data from the Dutch-Flemish PROMIS national center (personal communication, CB Terwee, April 29, 2021, and August 26, 2021) . For the PROMIS short forms self-efficacy medications and self-efficacy symptoms T scores were categorized as very high (+2 SD), high (+1 SD), average, low (−1 SD), and very low (−2 SD) for the construct being measured. In the absence of Dutch reference data, score cutoff values from the general US population were used to categorize these two PROMIS scores. In the general population, 84.1% scored within normal limits or the mildly deviant categories or the average, high, or very high categories. 42 Finally, a synthesis of the results on feasibility, measurement properties, and relevance was generated. In total, 373 adult patients with hemophilia were invited to participate in the study, 162 patients (43%) signed informed consent, but 6 did not proceed to answer the questionnaires, and 14 reported rel- Table 2 presents data on the number of items and floor and ceiling effects of the nine Dutch PROMIS item banks. The mean number of questions answered per CAT item bank varied from 5.2 (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] for satisfaction with participation to 8.7 (range, 5-12) for anxiety. In total, the legacy instruments contained 141 items, and the mean total number of PROMIS items completed was 57 (±13). Details on the number of items for the legacy instruments are shown in the Supporting Information. Floor effects were observed in two PROMIS item banks: the CATs pain interference (26% minimum scores) and depression (18% minimum scores). Patients had to administer the maximum of 12 CAT items when reporting minimum scores. Ceiling effects were observed in two PROMIS item banks: the short forms self-efficacy medications (28% maximum scores) and self-efficacy symptoms (22% maximum scores). Details on the proportions of lowest and highest scores for the legacy instruments are shown in the Supporting Information. Ceiling effects were observed for the RAND-36 domains physical functioning (26%), social functioning (49%), pain (28%), and role limitations due to physical health problems (64%), and for the HAL sum score (22%). Floor effects were observed for the VERITAS-Pro domains time (20%) and remember (22%). Results of construct validity and hypotheses testing of the PROMIS item banks compared to legacy instruments are shown in Table 3 . The hypotheses regarding expected differences between subgroups were confirmed for the PROMIS CATs domains physical function and participation ( Figure 1 and do not support the use of the PROMIS short forms on self-efficacy in adults with hemophilia. The generalizability of the study to other populations with compa- Note: Interpretation: PROMIS total scores are calculated by transforming the item-scores into T scores with 50 (based on the US population mean) with a SD of 10. For all item banks, higher scores represent more of the construct (eg, more pain interference or better physical function). Participation: ability to participate in social roles and activities; satisfaction with participation: satisfaction with social roles and activities; self-efficacy medications: self-efficacy for managing medications and treatment; self-efficacy symptoms: self-efficacy for managing symptoms. Abbreviations: CATs, computer adaptive tests; PROMIS, Patient Reported Outcomes Measurement Information System; self-efficacy symptoms, self-efficacy for managing symptoms. as the symptoms evaluated within these domains are generally less prevalent in hemophilia. 40, 45, 46 The lack of correlation between the PROMIS CAT domain participation and the legacy instruments was also affected by high scores and a narrow data range, which was also observed for the participation item bank in the Dutch general population. 16, 47 A limitation of the study is that reliability of the PROMIS item banks (SE) could not be compared with the legacy instruments Interpretation: N items: for the CATs the mean number of CAT items was shown. Floor/ceiling: + no floor-and/or ceiling effects, ± similar floor-and/ or ceiling effects as legacy instrument, -more floor-and/or ceiling effects than legacy instrument. Convergent validity: + predefined hypothesis was confirmed, -predefined hypothesis was not confirmed. Known-group validity: + predefined hypothesis was confirmed, -predefined hypothesis was not confirmed. Reliability: ++ >90% of the scores was reliable (SE ≤ 3.2), + >70% of the scores was reliable (SE ≤ 3.2), -<70% of the scores was reliable (SE ≤ 3.2). Relevance: + patients with hemophilia had more limited scores than the general population, -patients with hemophilia had fewer or similar limited scores than the general population. Finally, the use of reference data from the general population influenced the distribution of the categories of the PROMIS T scores. Proportions of abnormal scores were similar or lower than in Dutch men or the general US population, except for physical function and satisfaction with participation. This may be explained by a tendency that patients with lifelong conditions like hemophilia report higher health states than the general population, known as the disability paradox, suggesting the impact of hemophilia may be underestimated if general population references are used. 48 In the absence of Dutch male reference data, reference data of the general US population were used for the PROMIS item banks self-efficacy medications and self-efficacy symptoms, which may have affected the results. 49 The reported floor and ceiling effects for the legacy instruments Why should we use PROMIS above the legacy instruments in patients with hemophilia? As 66% of patient with hemophilia reported ≥1 comorbidity, the use of generic PROMIS item banks will be an efficient tool for outcome assessment while including the ability to consider ef- WFH guidelines for the management of hemophilia How to discuss gene therapy for haemophilia? A patient and physician perspective Emicizumab prophylaxis in hemophilia A with inhibitors Sports participation and sports injuries in Dutch boys with haemophilia Haemophilia and ageing Outcome measures in haemophilia: beyond ABR (annualized bleeding rate) Initial adult health item banks and first wave testing of the Patient-Reported Outcomes Measurement Information System Item response theory, computerized adaptive testing, and PROMIS: assessment of physical function Relationship between PROMIS computer adaptive tests and legacy hip measures among patients presenting to a tertiary care hip preservation center PROMIS ® adult health profiles: efficient short-form measures of seven health domains. Value Heal Assessing the test-retest reliability and smallest detectable change of the Haemophilia Activities List Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined Patient-Reported Outcomes Measurement Information System (PROMIS) instruments among individuals with symptomatic knee osteoarthritis: a cross-sectional study of floor/ceiling effects and construct validity Dutch-Flemish translation of 17 item banks from the Patient-Reported Outcomes Measurement Information System (PROMIS) Validation of two PROMIS item banks for measuring social participation in the Dutch general population Calibration and validation of the Dutch-Flemish PROMIS pain interference item bank in patients with chronic pain Psychometric properties of the PROMIS Physical Function item bank in patients receiving physical therapy Validation of a new instrument to measure disease-related distress among patients with haemophilia Sociodemographic, clinical, and psychosocial characteristics of people with hemophilia in Portugal: findings from the first national survey An evaluation of PROMIS health domains in adults with haemophilia: a cross-sectional study Fifty years of hemophilia treatment in the Netherlands (accepted for publication) COSMIN Study Design checklist for Patient-reported outcome measurement instruments Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List The Swedish version of the haemophilia activity list Health-related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties Psychometric qualities of the RAND 36-item health survey 1.0: a multidimensional measure of general health status Het meten van de algemene gezondheidstoestand met de Rand-36 Assessing quality of life in individuals with hereditary blood coagulation disorders Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia -the HEP-Test-Q VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia Development and testing of a short form of the patient activation measure Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form Patient Activation Measure (PAM-13) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures Using PROMIS for measuring recovery after abdominal surgery: a pilot study PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis Correlation coefficients: appropriate use and interpretation Health Measurement Scales. A Practical Guide to Their Development and Use PROMIS ® Score Cut Points Establishing minimum clinically important difference values for the Patient-Reported Outcomes Measurement Information System Physical Function, hip disability and osteoarthritis outcome score for joint reconstruction, and knee injury and osteoarthritis outcome score for joint reconstruction in orthopaedics Unravelling adherence to prophylaxis in haemophilia: a patients' perspective COVID-19 pandemic and mental health consequences: systematic review of the current evidence Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients Proposal to extend the PROMIS ® item bank v2.0 "Ability to Participate in Social Roles and Activities": item generation and content validity Evidence of a disability paradox in patient-reported outcomes in haemophilia International application of PROMIS computerized adaptive tests: US versus country-specific item parameters can be consequential for individual patient scores Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands Generic and disease-specific quality of life among youth and young men with hemophilia in Canada Patient-relevant health outcomes for hemophilia care: development of an international standard outcomes set The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia The authors thank CB Terwee and M Luijten for their help in interpreting the data. Additional supporting information may be found in the online version of the article at the publisher's website.